Evidence map›Paper›PMID 28779147›Full record

ArticleScientific reports2017

A novel secretion and online-cleavage strategy for production of cecropin A in Escherichia coli.

Meng Wang, Minhua Huang, Junjie Zhang, Yi Ma, Shan Li, Jufang Wang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields.Frontiers in cellular and infection microbiology · 2021
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Meng WangSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China.ORCID 0000-0001-9246-1581
Minhua HuangSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China.
Junjie ZhangSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China.
Yi MaSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China.
Shan LiSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China.
Jufang WangSchool of Bioscience and Bioengineering, South China University of Technology, Guangzhou, 510006, China. jufwang@scut.edu.cn.
South China University of Technology · CN

Funding

NICHD NIH HHS N01 AA021004
6 · The paper itself

Abstract

Antimicrobial peptides, promising antibiotic candidates, are attracting increasing research attention. Current methods for production of antimicrobial peptides are chemical synthesis, intracellular fusion expression, or direct separation and purification from natural sources. However, all these methods are costly, operation-complicated and low efficiency. Here, we report a new strategy for extracellular secretion and online-cleavage of antimicrobial peptides on the surface of Escherichia coli, which is cost-effective, simple and does not require complex procedures like cell disruption and protein purification. Analysis by transmission electron microscopy and semi-denaturing detergent agarose gel electrophoresis indicated that fusion proteins contain cecropin A peptides can successfully be secreted and form extracellular amyloid aggregates at the surface of Escherichia coli on the basis of E. coli curli secretion system and amyloid characteristics of sup35NM. These amyloid aggregates can be easily collected by simple centrifugation and high-purity cecropin A peptide with the same antimicrobial activity as commercial peptide by chemical synthesis was released by efficient self-cleavage of Mxe GyrA intein. Here, we established a novel expression strategy for the production of antimicrobial peptides, which dramatically reduces the cost and simplifies purification procedures and gives new insights into producing antimicrobial and other commercially-viable peptides.

Indexed as

Antimicrobial Cationic PeptidesCell MembraneEscherichia coliExtracellular SpaceMicrobial Sensitivity TestsProtein AggregatesProtein TransportProteolysisRecombinant Fusion ProteinsWorkflowAntimicrobial Cationic Peptidescecropin AProtein AggregatesRecombinant Fusion Proteins

Identifiers

PMID28779147
PMCPMC5544755
OpenAlexW2741154231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.